Fogorvosi szemle, 2008 (101. évfolyam, 1-6. szám)

2008-06-01 / 3. szám

98

FOGORVOSI SZEMLE

101. évf. 3. sz. 2008.

sal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000; 68: 2907-2915.

44. Kubert D, Rubin M, Barnett ML & Vincent JW: Antiseptic mouthrinse-induced microbial cell surface alterations. Amer J Dentistry 1993; 6: 277-279.

45. Lamster IB: The effect of Listerine antiseptic and reduction of existing plaque and gingivitis. Clin Prev Dent 1983; 5: 12-16.

46. Lang NP, Hotz P, Graf H, Geering et al: Effects of supervised chlorhexidine mouthrinses in children. A longitudinal clinical trial. J Periodont Res 1982; 17: 101-111.

47. Larsen T: Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiology and Immunology 2002; 17: 267-271.

48. Li YH, Hanna, MN, Svensater G, Ellen RP & Cvitkovitch DG: Cell density modulates acid adaptation in Streptococcus mutans: implications for survival in biofilms. Journal of Bacteriology 2001 ; 183: 6875-6884.

49. Li Y-H, Lau PCY, Tang N, Svensater G, Ellen RP & Cvitkovitch DG: Novel two-component regulatory system involved in biofilm formation and acid resistance in Streptococcus mutans. Journal of Bacteriology 2002; (a)184: 6333-6342.

50. Li Y-H, Tang N, Aspiras MB, Lau PCY, Lee JH, Ellen RP & Cvitkovitch DG: A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. Journal of Bacteriology 2002; (b)184: 2699-2708.

51. Lôe H, Theilade E, Jensen S: Experimental gingivitis in man. J Periodontol 1965; 36:177-187.

52. Lóé H, Schiott CR, Karring G, Karring T: Two years oral use of Chlorhexidine in man. I: General Design and clinical effects. J Periodontol Res 1976; 17: 135-144.

53. Marsh PD & Bowden GHW: Microbial community interactions in biofilms. In: Allison DG, Gilbert P, Lappin-Scott HM & Wilson M (eds.): Community Structure and Co-operation in Biofilms (Vol. Society for Microbiology Symposium 59), pp. 167—198. Cambridge, Cambridge University Press, 2000.

54. Marsh PD: Microbial ecology of dental plaque and its significance in health and disease. Advances in Dental Research 1984; 8: 263- 271.

55. Marsh PD & Bradshaw DJ (1999): Microbial community aspects of dental plaque. In: Newman HN & Wilson M (eds.): Dental Plaque Revisited, pp. 237-253. Cardiff: BioLine.

56. Marshall KC. Biofilms: An overview of bacterial adhesion, activity and control at surfaces. Am Soc Microbiol 1992; 58: 202-207.

57. Marsh PD: Are dental diseases examples of ecological catastrophes? Microbiology 2003; 149: 279-294.

58. Marsh PD: Dental plaque as a microbial biofilm. Caries Research 2004;38: 204-211.

59. Marsh PD: Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol 2005; 32: (Suppl. 6): 7-15.

60. Millward TA & Wilson M: The effect of chlorhexidine on Streptococcus sanguis biofilms. Microbios 1989; 58: 155-164.

61. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000; 289: 1560-1563.

62. Netuschil L, Weiger R, Preisler R & Brecx M: Plaque bacteria counts and vitality during chlorhexidine, meridol and listerine mouthrinses. European Journal of Oral Science 1995;103: 355-361.

63. Nichols WW: Biofilm permeability to antibacterial agents. In: Wimrenny J, Nichols W, Stickler D & Lappin-Scott H (eds.): Bacterial Biofilms and their Control in Medicine and Industry, pp. 141-149. Cardiff: BioLine (1994).

64. Noiri Y, Okami Y, Narimatsu M, Takahashi Y, Kawahara T & Ebisu S: Effects of chlorhexidine, minocycline, and metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol 2003;74: 1647-1651.

65. Overholser CD, Meiller TF, Depaola LG, Minah GE, Niehaus C: Comparative effets of 2 chemotherapeutic mouthrinses on the development of supragingival plaque and gingivitis. J Clin Periodontol 1990; 17: 575-579.

66. Pan P, Barnett ML, Coelho J, Brogdon C & Finnegan MB: Determination of the in situ bactericidal activity of an essential oil mouthrinse using a vital stain method. J Clin Periodontol 2000; 27: 256- 261.

67. Quirynen M, Teughels W, De Soete M & Van Steenberghe D: Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbiological aspects. Periodontology 2000 2002; 28: 72-90.

68. Pratten J & Wilson M: Antimicrobial susceptibility and composition of microcosm dental plaques supplemented with sucrose. Antimicrobial Agents and Chemotherapy 1999; 43: 1595-1599.

69. Roberts AP, Cheah G, Ready D, Pratten J, Wilson M & Mullany P: Transfer of TN916-like elements in microcosm dental plaques. Antimicrobial Agents and Chemotherapy 2001 ; 45: 2943-2946.

70. Ruby E, Henderson B, Mcfall-Ngai M: Microbiology. We get by with a little help from our (little) friends. Science 2004; 303: 1305- 1307.

71. Shani S, Friedman M, Steinberg D: The anticariogenic effect of amine fluorides on Streptococcus sobrinus and glucosyltransferase in biofilms. Caries Research 2000; 34: 260-267.

72. Shapiro JA: Thinking about bacterial populations as multicellular organisms. Annual Reviews of Microbiology 1998; 52: 81-104.

73. Socransky SS, Haffajee AD, Cugini, MA, Smith C, Kent RL: Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25: 134-144.

74. Socransky SS, Haffajee AD: Dental biofilms: difficult therapeutic targets. Periodontology 2000 2002; 28: 12-55.

75. Stewart PS & Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-138.

76. Strober W, Kelsall B, Marth T: Oral tolerance. J Clin Immunol 1998; 18: 1-30.

77. Sturme MH, Kleerebezem M, Nakayama J et al: Cell to cell communication by autoinducing peptides in Gram-positive bacteria. Antonie van Leeuwenhoek 81: 233-243. 2002.

78. Svensater G, Welin J, Wilkins JC, Beighton D & Hamilton IR: Protein expression by planktonic and biofilm cells of Streptococcus mutans. FEMS Microbiology Letters 2001; 205: 139-146.

79. Theilade E: The non-specific theory in microbial etiology of inflammatory periodontal disease. J Clin Periodontol 1986; 13: 905-911.

80. Tonetti MS, Imboden MA, Lang NP: Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1. J Periodontol 1998; 69: 1139-1147.

81. Veckman V, Miettinen M, Pirhonen J, Siren J, Matikainen S, Julkunen I: Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol 2004; 75: 764-771.

82. Weeks C, Briner W, Rebitski G. Vick V & Feller M: Immediate and prolonged effect of 0.12% chlorhexidine on salivary bacteria. J Dent Research 1988; 67: 326.

83. Welin J, Wilkins JC, Beighton D & Svensater G: Protein expression by Streptococcus mutans during initial stage of biofilm formation. Applied and Environmental Microbiology 2004; 70: 3736-3741.

84. Whitehead NA, Barnard AM, Slater H, Simpson NJ & Salmond GP: Quorum-sensing in Gram-negative bacteria. FEMS Microbiology Reviews 25, 365—404. 2001.

85. Wilson M: Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 1996; 44: 79-87.

86. Wirthlin MR & Armitage GC: Dental Plaque and Calculus: Microbial Biofilms and Periodontal Diseases, in: Rose L F & Mealey BL (eds): Periodontics, Medicine Surgery and Implants. Elsevier Mosby, 2004. 100-116. o.

87. Wolff LF: Chemotherapeutic agents in the prevention and treatment of periodontal disease. Northwest Dentistry 1985; 64: 15-24.

88. Yilmaz O, Young PA, Lamont RJ & Kenny GE: Gingival epithelial cell signalling and cytoskeletal responses to Porphyromonas gingivalis invasion. Microbiology 2003; 149: 2417-2426.